{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:41:21Z","timestamp":1760985681165},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.transproceed.2018.02.068","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:39:18Z","timestamp":1525437558000},"page":"1298-1304","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients"],"prefix":"10.1016","volume":"50","author":[{"given":"W.","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.02.068_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00007890-199801270-00018","article-title":"Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients","volume":"65","author":"Roth","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.068_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200107150-00014","article-title":"Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients","volume":"72","author":"Squifflet","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.068_bib3","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2007.01983.x","article-title":"Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation","volume":"7","author":"Le Meur","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.02.068_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e318186f98a","article-title":"Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial","volume":"86","author":"van Gelder","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.068_bib5","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1432-2277.2012.01553.x","article-title":"Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week","volume":"25","author":"Barraclough","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2018.02.068_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/TP.0b013e3182985491","article-title":"The national program for deceased organ donation in China","volume":"96","author":"Huang","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.068_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1440-1797.2011.01560.x","article-title":"A\u00a0limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients","volume":"17","author":"Barraclough","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.transproceed.2018.02.068_bib8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/FTD.0b013e3181fc8fbb","article-title":"Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients","volume":"32","author":"Barraclough","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2018.02.068_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.acc.2016.04.001","article-title":"Therapeutic drug monitoring of mycophenolic acid","volume":"76","author":"Dasgupta","year":"2016","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.transproceed.2018.02.068_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/bcp.12007","article-title":"Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation","volume":"75","author":"Musuamba","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/FTD.0000000000000165","article-title":"Limited sampling strategy for predicting area under the concentration-time curve for mycophenolic acid in Chinese adults receiving mycophenolate mofetil and tacrolimus early after renal transplantation","volume":"37","author":"Cai","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2018.02.068_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/FTD.0b013e31827efe37","article-title":"A\u00a0limited sampling strategy to estimate the area under the concentration-time curve of tacrolimus modified-release once-daily preparation in renal transplant recipients","volume":"35","author":"Niioka","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2018.02.068_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2018.02.068_bib14","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1191\/0961203305LU2109OA","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.transproceed.2018.02.068_bib15","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.transproceed.2004.08.087","article-title":"The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients","volume":"36","author":"Jirasiritham","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.02.068_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/0091270004266634","article-title":"Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients","volume":"44","author":"Cho","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1600-6135.2003.00243.x","article-title":"Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients","volume":"3","author":"Pescovitz","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.02.068_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/aps.2015.7","article-title":"Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients","volume":"36","author":"Xie","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.transproceed.2018.02.068_bib19","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2215\/CJN.03861106","article-title":"Therapeutic drug monitoring of mycophenolic acid","volume":"2","author":"Shaw","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00228-005-0927-4","article-title":"Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation","volume":"61","author":"Staatz","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1517\/17425250903114182","article-title":"Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review","volume":"5","author":"Bruchet","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/FTD.0b013e3181f01397","article-title":"Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients","volume":"32","author":"Chen","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2018.02.068_bib23","first-page":"4226","article-title":"Pharmacokinetics of enteric-coated mycophenolate sodium in Chinese renal transplantation recipients","volume":"125","author":"Qiu","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.transproceed.2018.02.068_bib24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/jcph.125","article-title":"Limited sampling strategy of mycophenolic acid in adult kidney transplant recipients: influence of the post-transplant period and the pharmacokinetic profile","volume":"53","author":"Chaabane","year":"2013","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.ftd.0000167885.17280.6f","article-title":"Determinants of mycophenolic acid levels after renal transplantation","volume":"27","author":"Borrows","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2018.02.068_bib26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00467-008-0877-z","article-title":"Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients","volume":"23","author":"Irtan","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trre.2010.06.001","article-title":"Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure","volume":"25","author":"Tett","year":"2011","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.transproceed.2018.02.068_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003088-200443040-00004","article-title":"Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients","volume":"43","author":"Le Guellec","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2018.02.068_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00228-014-1771-1","article-title":"Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil","volume":"71","author":"Ling","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00007691-200002000-00005","article-title":"Pharmacokinetics of mycophenolic acid in renal insufficiency","volume":"22","author":"Meier-Kriesche","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2018.02.068_bib31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/00912709922008353","article-title":"The effect of renal insufficiency on mycophenolic acid protein binding","volume":"39","author":"Kaplan","year":"1999","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V981511","article-title":"Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients","volume":"9","author":"Weber","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.068_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518302197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518302197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T11:34:47Z","timestamp":1635507287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518302197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0041134518302197"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.068","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}